Source comparison
Post Surgery Recovery Peptides 2026 Update: Peptide Comparison
BPC-157 Angiogenesis, NO pathway modulation, collagen synthesis Tendon/ligament repair, wound healing, GI mucosa protection Restricted. No longer available through 503A/B compounding; research-grade only Most direct wound-healing mechanism, but regulatory acce
This comparison does not assign a generated winner or score.
- BPC-157
- Angiogenesis, NO pathway modulation, collagen synthesis
- Tendon/ligament repair, wound healing, GI mucosa protection
- Restricted. No longer available through 503A/B compounding; research-grade only
- Most direct wound-healing mechanism, but regulatory access is the limiting factor
- TB-500
- Actin sequestration, cell migration, differentiation
- Muscle injury, post-surgical inflammation reduction
- Restricted. Same status as BPC-157 post-March 2026 enforcement
- Complementary to BPC-157; best for systemic inflammation and tissue remodeling
- Thymalin
- T-cell maturation, cytokine modulation
- Immune recovery post-surgery, infection prevention
- Available through research suppliers; limited clinical use
- Immune-focused rather than wound-focused. Useful in immunocompromised populations
- Cerebrolysin
- Neurotrophic factor upregulation (BDNF, NGF)
- Neurosurgical recovery, nerve regeneration
- Commercially available in some regions; IND coverage in U.S.
- Niche application; most relevant for neurological procedures
- MK 677
- Ghrelin receptor agonism, GH/IGF-1 elevation
- Systemic anabolic support, bone density, collagen synthesis
- Widely available; not classified as a drug
- Indirect mechanism; supports recovery but doesn't replace localized repair peptides